Web Results

CV - Rutgers Translational Sciences - Rutgers University

rts.rutgers.edu/sites/ots.rutgers.edu/files/David J. Augeri - CV.pdf

Senior Research Investigator I, II Bristol-Myers Squibb. Discovery of Onglyza ( Saxagliptin), co-inventor, FDA Approval,. August 2009. ... Salojin Konstantin V; Hamman Brian D; Chang Wei Chun; Jhaver Kanchan G; Al-. Shami Amin ... Tarver, James E.; Jessop, Theodore C.; Carlsen, Marianne; Augeri, David J.; Fu,. Qinghong ...

To have and have not: Health and health care disparities in chronic ...


... Dialysis Clinic, Incorporated; and Bristol-Myers Squibb Company. ..... A study by Evans et al suggested that health insurance for renal replacement therapy ..... Tarver-Carr, ME, Powe, NR, Eberhardt, MS, et al: Excess risk of chronic kidney ... renal function decline in blacks vs whites with diabetes: The Atherosclerosis Risk  ...

Hypertensive nephrosclerosis in African Americans - Nature


... Co., Incorporated; Dialysis Clinic, Incorporated; and Bristol-Myers Squibb Company. ..... In a long-term follow-up study of hypertensive patients, Perry et al demonstrated that ..... Dr. V. S. Balakrishnan (Division of Nephrology, Tufts-New England Medical Center): .... TARVER-CARR ME, POWE NR & EBERHARDT MS et al.

AMSRJ Spring 2014 Pages 1 - 50 - Text Version | FlipHTML5


May 26, 2014 ... Lucke-Wold et al. provide a risk factor analysis of ischemic stroke, identifying ... would like to thank Dr. Tak Yee Aw, Julia Esparza, and Talicia Tarver. ..... Surgical fixation vs nonoperative management of flail chest: a meta- analysis. ..... Bristol-Myers Squibb Company, Princeton, to benefit both patients and ...

Serum Bicarbonate Levels and the Progression of Kidney Disease ...


Apr 25, 2009 ... Sensitivity analyses – Co-variate definitions ... Excluded patients were more likely to be women (74% vs. .... Rustom et al. followed 11 patients with mild to moderate renal impairment ... Dr Hostetter has consulted for Bristol Myers Squibb, Eli Lilly and Wyeth. ... Tarver-Carr ME, Powe NR, Eberhardt MS, et al.

Glucocorticoid Inhibits Thrombin-induced Expression of Platelet ...


grant for cardiovascular research from Bristol-Myers Squibb Com- pany (to R. R.) ... proliferation of smooth muscle cells (SMCs) (Ross et al., 1986;. Raines et al. ... 1975; Ehrlich and Tarver, 1971). ..... provided by Mochida Pharmaceutical Co., Ltd. (Tokyo, Japan). .... Naftilan, A. J., Pratt, R. E., and Dzau, V. J. (1989) J. Clin.

Extracellular Mutations of Protease-Activated Receptor-1 Result in ...


Dec 1, 2000 ... All chemicals were from Sigma Chemical Co. ... PI determination was done as described in Nanevicz et al. ..... TRAP: thrombin receptor agonist peptide; BMS: Bristol-Myers Squibb; PI: phosphoinositide .... Molino M,; Blanchard N,; Belmonte E,; Tarver AP,; Abrams C,; Hoxie JA,; Cerletti C, and; Brass LF.

C--H functionalisation in organic synthesis themed ... - RSC Publishing


Aug 15, 2011 ... ... at Bristol-. Myers Squibb-New Brunswick under the guidance of Drs Jeffrey ... fellow and a BMS Minority Chemist fellow (2009–2011). .... amination with a Co(II ) porphyrin catalyst (Scheme 7).17 ..... Rev., 2010, 110, 824–889; (v) T. W. Lyons and ... Chem., Int. Ed., 1998, 37, 2580–2627; (e) E. T. Michalson.

Nearest Neighbor Networks - BMC Bioinformatics - BioMed Central


In Stuart et al, a metagene was defined as a set of genes across multiple organisms ..... Myers et al discusses the problems raised in coexpression analysis by ..... Thorsson V, Siegel AF, Hood LE: Testing for differentially- expressed genes by .... Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, ...

Gene Expression Profiling in Chemoresistant Variants of Three Cell ...


Etoposide (VP) Bristol Myers Squibb, Denmark; and Doxorubicin. (DOX) Pfizer Aps ... using NucleoTrap mRNA Mini Kit (Machery-Nagel GmBH & Co.,. Duren ... Johnsson et al: Gene Expression in Resistant Cell Lines. 2663. Table II ... in the up-regulated genes and sensitive vs. resistant in the down-regulated genes. Genes ...

Helpful Resources

status report (PDF) - AboutLawsuits.com


Jun 6, 2013 ... Co., No. 3:12-cv-04478; Raynor v. Bristol-Myers Squibb Co., No. .... Tarver v. Bristol-Myers Squibb Co., No. 3:13- cv-2262 (E.D. La.); Touriac v. Chenevert ... Hood v. Bristol-Myers Squibb Co., et al., 1:12-cv-00179 (N.D. Miss.).



BRISTOL-MYERS SQUIBB COMPANY v. APOTEX, INC. et al, No. 3: 2010cv05810 - Document 142 (D.N.J. 2013) case opinion from the District of New Jersey ...

Bristol-Myers Escapes $3.4B Apotex Suit Over Plavix Deal - Law360


Mar 14, 2013 ... Bristol-Myers Squibb Co. and partner Sanofi-Aventis SA won a defense verdict Wednesday in a $3.4 billion ... The case is Apotex Inc. et al. v.

Drug and Device Law: Innovator Liability at 100


Jul 18, 2014 ... Certainly not years; the awful Conte v. .... Innovator liability has been statutorily abolished in Alabama: ..... Indiana has a product liability statute, Ind. Code §34- 20-1-1, et seq., that applies to all .... May 10, 2006); Tarver v. ... Bristol-Myers Squibb Co., 121 F. Supp.2d 831, 836-837 (D. Md. 2000) (granting ...



Oct 1, 2012 ... See Docket. 2 Sanofi-Aventis U.S., LLC is a pharmaceutical company that is incorporated in Delaware and ... Ambien pursuant to Wyeth v. Levine .... Bristol- Myers Squibb, 127 Wash.App. 335 .... May 10, 2006); Tarver v. Wyeth ...